Glioblastoma News and Research

RSS
Glioblastoma is the most aggressive and malignant form of glioma, a type of primary brain cancer. Surgery is often used to treat gliomas, along with radiation. However, since surgery and radiation fail to cure the disease, doctors may turn to additional radiation or chemotherapy. In early stages glioblastoma tumors often grow without symptoms and therefore can become quite large before symptoms arise. When the tumor becomes symptomatic, tumor growth is usually very rapid and is accompanied by altered brain function, and if left untreated the disease becomes lethal. Although primary treatment is often successful in temporarily stopping the progression of the tumor, glioblastomas almost always recur and become lethal.
New discovery offers hope for stopping childhood brain tumors before they start

New discovery offers hope for stopping childhood brain tumors before they start

USC receives $6 million grant for pioneering glioblastoma gene therapy

USC receives $6 million grant for pioneering glioblastoma gene therapy

Early detection of tumor spread improves treatment outcomes

Early detection of tumor spread improves treatment outcomes

Study reveals route of entry for Semliki Forest virus into the brain

Study reveals route of entry for Semliki Forest virus into the brain

New brain stem cell discovery could usher in better treatments for glioblastoma

New brain stem cell discovery could usher in better treatments for glioblastoma

Scientists discover new target for treating aggressive brain cancer

Scientists discover new target for treating aggressive brain cancer

New nanoparticle platform delivers drug pairs to specific cancer types

New nanoparticle platform delivers drug pairs to specific cancer types

New insights into glioblastoma resistance to temozolomide

New insights into glioblastoma resistance to temozolomide

Brain tumors exploit body's daily rhythms to fuel growth

Brain tumors exploit body's daily rhythms to fuel growth

Scientists discover key protein that helps cancer cells evade CAR T cell therapy

Scientists discover key protein that helps cancer cells evade CAR T cell therapy

New radiation therapy approach improves survival for older glioblastoma patients

New radiation therapy approach improves survival for older glioblastoma patients

Targeted gene therapy shuts down cancer cells' energy centers

Targeted gene therapy shuts down cancer cells' energy centers

Disrupting the circadian rhythm of glioblastoma slows tumor growth, study says

Disrupting the circadian rhythm of glioblastoma slows tumor growth, study says

Lab-grown tumor organoids predict patient response to CAR T cell therapy

Lab-grown tumor organoids predict patient response to CAR T cell therapy

New technology guides immune cells to fight brain cancer and multiple sclerosis

New technology guides immune cells to fight brain cancer and multiple sclerosis

MRI-based imaging technique predicts the response of ovarian cancer to treatment

MRI-based imaging technique predicts the response of ovarian cancer to treatment

New collaborative effort aims to cure ALK-positive lung cancer

New collaborative effort aims to cure ALK-positive lung cancer

New immune therapy improves survival and reduces tumor burden in glioblastoma

New immune therapy improves survival and reduces tumor burden in glioblastoma

New study unveils why glioblastoma becomes resistant to treatment

New study unveils why glioblastoma becomes resistant to treatment

Small brain-penetrating molecule offers hope for treating aggressive brain tumors

Small brain-penetrating molecule offers hope for treating aggressive brain tumors

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.